Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.2, replacing v3.2.0. This is a system version update and does not alter trial details or records.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The funding-delay notice on the page was removed, eliminating guidance about data currency during government funding gaps. This may reduce visibility into the page's reliability context for updates.
    Difference
    0.5%
    Check dated 2025-11-17T20:05:55.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Both screenshots show the same Record History page for NCT03131908 with identical version entries and controls; any differences appear to be visual/UI adjustments rather than content updates.
    Difference
    0.1%
    Check dated 2025-11-03T13:49:11.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    11%
    Check dated 2025-10-06T04:22:11.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T23:40:40.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.6%
    Check dated 2025-09-14T10:01:19.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.